Givaudan SA

“Givaudan is one of the highest-quality consumer ingredients businesses globally — a true oligopoly leader with a deep, widening moat, secular tailwinds, and predictable cash flows. The 2022-2023 destocking dip was cyclical, and the 8.5% LFL recovery in 2024 confirms the structural flywheel is intact. However, the stock at CHF 2,778 (24x trailing, 21.5x forward) is fairly priced rather than cheap: the earnings recovery is largely priced in, the balance sheet carries residual M&A leverage from the Frutarom era, and the incoming CEO has yet to demonstrate strategic conviction. At decade-low multiples, long-term holders should hold with confidence, but new capital should wait for an entry in the CHF 2,400–2,500 range where the margin of safety widens enough to justify initiating a position.”